Evidence map›Paper›PMID 35077611›Full record

Observational studyJournal of the International AIDS Society2022

Uptake of community- versus clinic-based antiretroviral therapy dispensing in the Central Chronic Medication Dispensing and Distribution program in South Africa.

Ingrid V Bassett, Joyce Yan, Sabina Govere, Anele Khumalo, Nompumelelo Ngobese, Zinhle Shazi, Mpilonhle Nzuza, Bridget A Bunda, Nafisa J Wara, Ashley Stuckwisch and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Monitoring patients on ART within the CCMDD programme and those attending an urban healthcare facility in KwaZulu-Natal.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2024
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Ingrid V BassettMassachusetts General Hospital, Division of Infectious Diseases, Boston, Massachusetts, USA.ORCID 0000-0001-6920-6080
Joyce YanMassachusetts General Hospital, Biostatistics Center, Boston, Massachusetts, USA.
Sabina GovereAIDS Healthcare Foundation, Durban, South Africa.
Anele KhumaloAIDS Healthcare Foundation, Durban, South Africa.
Nompumelelo NgobeseAIDS Healthcare Foundation, Durban, South Africa.
Zinhle ShaziAIDS Healthcare Foundation, Durban, South Africa.
Mpilonhle NzuzaAIDS Healthcare Foundation, Durban, South Africa.
Bridget A BundaMassachusetts General Hospital, Medical Practice Evaluation Center, Boston, Massachusetts, USA.
Nafisa J WaraMassachusetts General Hospital, Medical Practice Evaluation Center, Boston, Massachusetts, USA.
Ashley StuckwischMassachusetts General Hospital, Medical Practice Evaluation Center, Boston, Massachusetts, USA.
Dani ZiontsMassachusetts General Hospital, Medical Practice Evaluation Center, Boston, Massachusetts, USA.
Nduduzo DubeAIDS Healthcare Foundation, Durban, South Africa.
Sandile TshabalalaSouth Africa Department of Health, Province of KwaZulu-Natal, South Africa.
Laura M BogartRAND Corporation, Santa Monica, California, USA.
Robert A ParkerCenter for AIDS Research (CFAR), Harvard University, Boston, Massachusetts, USA.
AIDS Healthcare Foundation · USMassachusetts General Hospital · USHarvard University · USAfrica Health Research Institute · ZARAND Corporation · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
South Africa's new Central Chronic Medicine Dispensing and Distribution program: assessing the clinic, patient, and community impactR01MH114997 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BASSETT, INGRID VALERIE · 2018 to 2022
$3.4M
NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH114997
6 · The paper itself

Abstract

introductionSouth Africa's government-led Central Chronic Medication Dispensing and Distribution (CCMDD) program offers people living with HIV the option to collect antiretroviral therapy at their choice of community- or clinic-based pick-up points intended to increase convenience and decongest clinics. To understand CCMDD pick-up point use among people living with HIV, we evaluated factors associated with uptake of a community- versus clinic-based pick-up point at CCMDD enrolment.

methodsWe collected baseline data from October 2018 to March 2020 on adults (≥18 years) who met CCMDD clinical eligibility criteria (non-pregnant, on antiretroviral therapy for ≥1 year and virologically suppressed) as part of an observational cohort in seven public clinics in KwaZulu-Natal. We identified factors associated with community-based pick-up point uptake and fit a multivariable logistic regression model, including age, gender, employment status, self-perceived barriers to care, self-efficacy, HIV-related discrimination, and perceived benefits and challenges of CCMDD. RESULTS AND DISCUSSION: Among 1521 participants, 67% were females, with median age 36 years (IQR 30-44). Uptake of a community-based pick-up point was associated with younger age (aOR 1.18 per 10-year decrease, 95% CI 1.05-1.33), being employed ≥40 hours per week (aOR 1.42, 95% CI 1.10-1.83) versus being unemployed, no self-perceived barriers to care (aOR 1.42, 95% CI 1.09-1.86) and scoring between 36 and 39 (aOR 1.44, 95% CI 1.03-2.01) or 40 (aOR 1.91, 95% CI 1.39-2.63) versus 10-35 on the self-efficacy scale, where higher scores indicate greater self-efficacy. Additional factors included more convenient pick-up point location (aOR 2.32, 95% CI 1.77-3.04) or hours (aOR 5.09, 95% CI 3.71-6.98) as perceived benefits of CCMDD, and lack of in-clinic follow-up after a missed collection date as a perceived challenge of CCMDD (aOR 4.37, 95% CI 2.30-8.31).

conclusionsUptake of community-based pick-up was associated with younger age, full-time employment, and systemic and structural factors of living with HIV (no self-perceived barriers to care and high self-efficacy), as well as perceptions of CCMDD (convenient pick-up point location and hours, lack of in-clinic follow-up). Strategies to facilitate community-based pick-up point uptake should be tailored to patients' age, employment, self-perceived barriers to care and self-efficacy to maximize the impact of CCMDD in decongesting clinics.

Indexed as

HIV InfectionsAdultAmbulatory Care FacilitiesCohort StudiesFemaleHumansMaleSouth AfricaAfricaARVcohort studiescommunitydifferentiated careHIV care continuum

Identifiers

PMID35077611
PMCPMC8789242
OpenAlexW4207021365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.